Hellmann MD, Janne PA, Opyrchal M, Hafez N, et al. Entinostat plus Pembrolizumab in Patients with Metastatic NSCLC Previously Treated with Anti-PD-(L)1 Therapy. Clin Cancer Res 2021;27:1019-1028.
PMID: 33203644